| Type | Valeur |
|---|---|
| lei | 213800G74QWY15FC3W71 |
| tidm | STX |
| Date | Type | Insider | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 20 janv. 2021 | PURCHASE | Hans Peter Hasler | 100 000 | 0.59 GBP | |
| 19 janv. 2021 | PURCHASE | Tim Watts | 100 000 | 0.60 GBP | |
| 11 déc. 2020 | PURCHASE | Tim Watts | 100 000 | 0.70 GBP | |
| 13 août 2019 | PURCHASE | James Karis | 75 000 | 1.78 GBP | |
| 26 avr. 2019 | PURCHASE | Mark Raymond Sampson | 22 875 | — | |
| 26 avr. 2019 | PURCHASE | Julie Karen Sampson | 22 042 | — | |
| 16 avr. 2019 | EXERCISE | Carl Sterritt | 123 690 | 0.01 GBP | |
| 17 avr. 2019 | PURCHASE | James Karis | 46 000 | — | |
| 17 avr. 2019 | PURCHASE | James Karis | 4 000 | — | |
| 21 sept. 2018 | PURCHASE | Carl Sterritt | 88 235 | 0.34 GBP | |
| 15 mai 2018 | PURCHASE | Carl Sterritt - Founder, Director and PDMR Mark Sampson - PDMR | 970 867 | 0.01 GBP | |
| 15 mai 2018 | PURCHASE | Shield Therapeuticsplcentité | 317 184 | 0.01 GBP | |
| 25 janv. 2018 | PURCHASE | Mark Sampson | 38 784 | — | |
| 25 janv. 2018 | PURCHASE | Mark Sampson | 27 658 | — | |
| 04 oct. 2017 | PURCHASE | Carl Sterritt | 8 814 | 1.00 GBP | |
| 11 juil. 2017 | PURCHASE | Shield Therapeuticsplcentité | 263 512 | 0.01 GBP | |
| 11 juil. 2017 | PURCHASE | Shield Therapeuticsplcentité | 19 048 | 1.57 GBP | |
| 12 sept. 2016 | PURCHASE | Shield Therapeuticsplcentité | 92 767 | 0.01 GBP |